Back to Awarded Treatment Trials


Awarded Trial: 18T-003

Grant ID

18T-003

Illness

Schizophrenia

Primary Drug/Intervention

Cromoglycate

Primary Dosage

41.6 mg per day (5.2 mg per spray, 1 spray each nostril four times per day)

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Preparing to start

Investigator

Vishwajit Nimgaonkar

Sample Size

100

Duration of Study Period for Each Subject

70 days

Outcome Measurements

N/A

Results

N/A

Publication

N/A

Link

N/A

PI Name

Vishwajit Nimgaonkar

Degree

N/A

Center

Psychiatry and Human Genetics

Institution

University of Pittsburgh

Address

3811 O'Hara Street

City or Town

Pittsburgh

State or Province

PA

Zip or Postal Code

15213

Country

USA

Email Address

vishwajitNL@upmc.edu